EyePoint Pharmaceuticals, Inc. (EYPT) has a market capitalization of $1.2B and trades at $14.34. The 52-week range is 3.91-19.11.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.5, Earnings Per Share (EPS) of $-3.17, annual revenue of $31.37M.
The stock has a beta of 1.91, operates in the Healthcare sector.
